McKee Charlotteinsider trades
In SEC Form 4 filings, McKee Charlotte is listed as CMO and Head of R&D of Sionna Therapeutics, Inc. (SION). McKee Charlotte reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 18.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| SIONSionna Therapeutics, Inc. | CMO and Head of R&D | 4 | Sep 18 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-18
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| SIONSionna Therapeutics, Inc. | Sep 17 | Sep 18 | A | 50,000 | $0.00 | $0 | 78,415 | No | Form 4 |
| SIONSionna Therapeutics, Inc. | Sep 17 | Sep 18 | A | 50,000 | $0.00 | $0 | 128,415 | No | Form 4 |
| SIONSionna Therapeutics, Inc. | Sep 17 | Sep 18 | A · derivative | 155,700 | $7.18 | $1,117,926 | 155,700 | No | Form 4 |
| SIONSionna Therapeutics, Inc. | Sep 17 | Sep 18 | D · derivative | 155,700 | $39.21 | $6,104,997 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.